Skip to content

Clinical trials

Completed Autoimmune Diseases trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Status: Completed Country / region: South Korea Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20102
20111
20122
20132
20151
20181
20191
20203
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Human Genome Sciences Inc., a GSK Company2
Pfizer2
Seoul National University Hospital2
Anthera Pharmaceuticals1
Eli Lilly and Company1
Genexine, Inc.1
GlaxoSmithKline1
Human Genome Sciences Inc.1
Jae Ho Byun1
Keio University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases16
Lupus Erythematosus, Systemic6
Arthritis, Rheumatoid4
Immune System Diseases3
Connective Tissue Diseases2
Glomerulonephritis2
Kidney Diseases2
Nephritis2
Rheumatic Diseases2
Sjogren's Syndrome2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.